Skip to main content

Day: April 18, 2023

SAB Biotherapeutics Announces U.S. FDA Grants Breakthrough Therapy Designation to SAB-176 Influenza Immunotherapy

SAB-176 has now received both Breakthrough and Fast Track designations from FDA – signifying its potential to fundamentally improve influenza treatment and prophylaxis Influenza therapeutic now eligible for intensive guidance from FDA for an efficient development program SAB-176 is the first fully-human multi-epitope binding broadly neutralizing immunoglobulin antibody therapeutic being developed for treatment of high-risk patients and for post-exposure prophylaxis of Type A and Type B influenza SIOUX FALLS, S.D., April 18, 2023 (GLOBE NEWSWIRE) — SAB Biotherapeutics (Nasdaq: SABS), (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human, multi-epitope binding immunoglobulin (hIgG, or fully human polyclonal) antibodies, without the need...

Continue reading

CVR Energy to Release First Quarter 2023 Earnings Results

SUGAR LAND, Texas, April 18, 2023 (GLOBE NEWSWIRE) — CVR Energy, Inc. (NYSE: CVI) plans to release its first quarter 2023 earnings results on Monday, May 1, after the close of trading on the New York Stock Exchange. The Company also will host a teleconference call on Tuesday, May 2, at 1 p.m. Eastern to discuss these results. This call, which will contain forward-looking information, will be webcast live and can be accessed on the Investor Relations section of CVR Energy’s website at www.CVREnergy.com. For investors or analysts who want to participate during the call, the dial-in number is (877) 407-8291. The webcast will be archived and available for 14 days at https://edge.media-server.com/mmc/p/iack3rjy. A repeat of the call also can be accessed for 14 days by dialing (877) 660-6853, conference ID 13737894. CVR Energy’s first...

Continue reading

Redflow receives California SGIP approval for its safe, scalable, and sustainable energy storage solutions

Approval signifies continuing rapid commercial progress in California BRISBANE, Australia, April 18, 2023 (GLOBE NEWSWIRE) — Redflow Limited (ASX: RFX), a global leader in clean energy storage, announced today that its safe, scalable, and sustainable energy storage solutions have been approved by the California Public Utilities Commission (“CPUC”) as eligible for the state’s Self-Generation Incentive Program (“SGIP”). SGIP provides rebates to support existing, new, and emerging energy storage resources in California that, when installed, are able to meet all or a portion of the electrical energy needs of a facility. Current SGIP rebates for qualifying distributed energy storage systems installed on the customer’s side of the utility meter can range up to USD $1,000 per kilowatt-hour, with the highest amounts for...

Continue reading

Saratoga Investment Corp. to Report Fiscal Fourth Quarter and Full Year 2023 Financial Results and Hold Conference Call

NEW YORK, April 18, 2023 (GLOBE NEWSWIRE) — Saratoga Investment Corp. (NYSE:SAR), a business development company, will report its financial results for the fiscal quarter and year ended February 28, 2023, on Tuesday May 2, 2023, after market close. A conference call to discuss the financial results will be held on Wednesday May 3, 2023. Details for the conference call are provided below.Who: Christian L. Oberbeck, Chairman and Chief Executive Officer  Michael J. Grisius, Chief Investment Officer  Henri J. Steenkamp, Chief Financial Officer, Chief Compliance Officer, Treasurer and Secretary   When: Wednesday, May 3, 2023  12:00 p.m. Eastern Time (ET)   How: Webcast: Interested parties may access a live webcast of the call and find the Q4 2023 presentation by going to the “Events & Presentations” section...

Continue reading

Bright Green Announces Fourth Quarter 2022 Financial Update

Continued investment to support long-term strategy and pathway for growth, including plans to fully acquire Alterola Biotech, appointment of Seamus McAuley as Chief Executive Officer and expansion of Scientific Advisory Board Recently announced capital raise plan of $500+ million utilizing the U.S. Citizen & Immigration Services EB-5 program, alongside the recently announced full acquisition of Alterola Biotech, showcases the Company’s significant progress against its strategic plan Company preparing for federal registration from U.S. Drug Enforcement Administration as bulk cannabis manufacturer, which will position Bright Green to become the largest, fully integrated operation for marijuana cultivation in the U.S. for research, medical and pharmaceutical applications and affiliated import and export GRANTS, N.M., April 18, 2023...

Continue reading

Solidus Communications, Inc. is Pleased to Report on Direction, Growth, and Acquisitions

ORMOND BEACH, FL, April 18, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Solidus Communications, Inc. (“Solidus” or the “Company”) (OTCPK: QBAND) (OTCPK: SLDC) is pleased to report on direction, growth, and acquisitions. Dear Shareholders, Solidus Communications is pleased to announce the following completed goals. 2023 will be a pivotal year for Solidus Communications. FINRA announced the Company’s corporate action/name change to Solidus Communications, Inc., and its new ticker symbol, “SLDC”. SLDC will become effective on/after 4/24/2023. Solidus Communications completed its audit of financial statements for the years 2015, and 2016, bringing the company into compliance with prior SEC requirements. Solidus Communications divested its non-telecommunication related subsidiary, Naked Papers Brand during Q1 of 2023. “The divestiture...

Continue reading

Lisata Therapeutics and WARPNINE Announce First Patient Treated in the iLSTA Trial of LSTA1, a Novel Tumor-Targeting and Penetrating Peptide, in Patients with Locally Advanced Non-Resectable Pancreatic Ductal Adenocarcinoma

The iLSTA Trial is the first study combining LSTA1 with standard-of-care chemotherapy and immunotherapy WARPNINE to provide funding and local trial management BASKING RIDGE, N.J. and SUBIACO, Australia, April 18, 2023 (GLOBE NEWSWIRE) — Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, and WARPNINE Incorporated (“WARPNINE”), Western Australia’s first not-for-profit clinical research organization for pancreatic, gastro-intestinal and rare cancers, today announced the treatment of the first patient in the iLSTA Trial of Lisata’s LSTA1 in combination with standard-of-care chemotherapy and immunotherapy as a first-line treatment in locally advanced non-resectable pancreatic...

Continue reading

ARHT Media Announces Fiscal 2022 Operating Results

Record revenue of $7.5M in 2022 (+58% YoY), including $2.1M in Q4 Introduction of CAPSULE display technology World’s largest network of holographic studios grows to over 50 locations Permanent installations take over events as main source of revenue showing growing demand for hologramsTORONTO, April 18, 2023 (GLOBE NEWSWIRE) — ARHT Media Inc. (“ARHT” or “the Company”) (TSXV: ART), (OTCQB: ARHTF) the global leader in the development, production and distribution of high-quality, low latency hologram and digital content, today announced its financial operating results for the fourth quarter and fiscal year ended December 31, 2022. 2022 Financial UpdateRevenues for Fiscal Year 2022 reached $7.5M, a 58% increase compared to $4.8M in Fiscal Year 2021Q4 2022 revenues rose to $2.1M, a 61% increase from $1.3M...

Continue reading

CVR Partners to Release First Quarter 2023 Earnings Results

SUGAR LAND, Texas, April 18, 2023 (GLOBE NEWSWIRE) — CVR Partners, LP (NYSE: UAN), a manufacturer of ammonia and urea ammonium nitrate (UAN) solution fertilizer products, plans to release its first quarter 2023 earnings results on Monday, May 1, after the close of trading on the New York Stock Exchange. The Partnership also will host a teleconference call on Tuesday, May 2, at 11 a.m. Eastern to discuss these results. This call, which will contain forward-looking information, will be webcast live and can be accessed on the Investor Relations section of CVR Partners’ website at www.CVRPartners.com. For investors or analysts who want to participate during the call, the dial-in number is (877) 407-8029. The webcast will be archived and available for 14 days at https://edge.media-server.com/mmc/p/8nwfybak. A repeat of the call also...

Continue reading

K92 Mining Appoints Anne Giardini as Chair of the Board

VANCOUVER, British Columbia, April 18, 2023 (GLOBE NEWSWIRE) — K92 Mining Inc. (“K92” or the “Company”) (TSX: KNT; OTCQX: KNTNF) is pleased to announce the appointment of Anne E. Giardini as the Company’s Chair of the Board of Directors. Ms. Giardini, KC, who has served as an independent director of K92 since 2020, brings 35 years of experience as a director, senior executive, lawyer, journalist and author. She has extensive expertise in the areas of strategy, governance, public reporting, financings, mergers and acquisitions, aboriginal affairs, safety, environment, government relations, litigation, and employment and labour matters. A long-time leader within Canada’s resource industry, Ms. Giardini had a +20-year career with Weyerhaeuser, including as General Counsel and subsequently President of Weyerhaeuser’s Canadian...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.